Skip to content

Lifestyle Intervention for Improving Insulin Resistance and Concern for Health

Lifestyle Intervention for Improving Metabolic and Motivational Outcomes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05649176
Enrollment
40
Registered
2022-12-13
Start date
2023-02-13
Completion date
2025-10-27
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apathy, Insulin Sensitivity

Brief summary

The primary objective of this study is to test the effect of a diet and exercise program in older adults with insulin resistance and a motivation disorder known as apathy. The main questions the study aims to answer are: 1. Does the diet and exercise program improve insulin resistance and apathy? 2. Does the addition of soybean to the diet enhance the effect? Participants will be given all meals for 12 weeks and will exercise under supervision. They will undergo a test of insulin sensitivity and complete questionnaires. Researchers will compare the groups given: 1. A diet to moderate the blood glucose response that contains soybean; and 2. A diet to moderate the blood glucose response that does not contain soybean.

Detailed description

This randomized trial will examine the blood glucose moderating effect of a diet and exercise program in 40 older adults with obesity, insulin resistance, and apathy. The primary objective of this study is to examine the effect of a diet and exercise program on insulin sensitivity and apathy and determine if the addition of soybean to the diet enhances the effect. The primary outcomes of the study are insulin sensitivity measured using the hyperinsulinemic euglycemic clamp test and apathy evaluated using the Apathy Evaluation Scale.

Interventions

OTHERDiet without soy

The diet is designed to moderate the blood glucose response with a similar macronutrient composition as the experimental diet but does not contain soy.

OTHERDiet with soy

The diet is designed to moderate the blood glucose response with a similar macronutrient composition as the comparator diet but contains soy.

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

This is a feeding study. All participants will receive a diet designed to moderate the blood glucose response. The diets will be similar except that in the experimental group soybean flour (soy) will be incorporated into the foods

Intervention model description

Randomized controlled two-arm parallel trial

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Body mass index (BMI) greater than or equal to 30kg/m2 * Mini-Mental State Examination (MMSE) \> 25 * Geriatric Depression Scale-15 (GDS-15) \< 6 * Apathy Evaluation Scale - score \> 30 or GDS-15 Apathy subscale - score ≥ 2 * Homeostatic model assessment of insulin resistance (HOMA-IR) ≥ 3 * Sedentary: \< 90 minutes of moderate to vigorous physical activity/week.

Exclusion criteria

* Subjects with a diagnosis of Type 2 diabetes received more than five years ago. * Participants who have type 1 diabetes * Participants being treated with prescription or over the counter medications that have a significant effect on insulin resistance, obesity, high density lipoprotein cholesterol, triglycerides, metabolic rate and those that significantly increase body weight. * Participants who are on concomitant therapy with glucocorticoids. * Participants with evidence and/or history (within the preceding 6 months) of significant gastrointestinal dysfunction. * Participants that have had a fluctuation in body weight \>5% in the preceding 2 months. * Any other conditions that may impede testing of the study hypothesis.

Design outcomes

Primary

MeasureTime frameDescription
Insulin sensitivity12 weeksInsulin sensitivity will measured in a hyperinsulinemic euglycemic clamp test

Secondary

MeasureTime frameDescription
Apathy as assessed by the Apathy Evaluation Scale12 weeksThe score on the Apathy Evaluation Scale ranges from 18 to 72 with higher scores indicating greater apathy.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCandida J Rebello

Pennington Biomedical Research Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026